United States · Funded startup

Who invested in TELA Bio

6 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$138Mraised across 6 rounds since 2013, from 6 sources

$6.0MGrowth$45MVenture$500KVenture$25MRound$1.0MRound$60MDebt
Latest round
Debt, $60MNov 2025
Step-upi
60×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2013201520172019202120232025
$6.0MGrowth$45MVenture$500KVenture$25MRound$1.0MRound$60MDebt
First round
Growth, $6.0M
Aug 2013
Biggest round
$60M
Debt · Nov 2025
Usual gap between rounds
14 months
the median of 5

The rounds

  1. Nov 2025
    Debt$60M2 new

    Source recorded

  2. Mar 2018
    Round$1.0M1 new

    Reported by FinSMEsSEC filing: $500K sold, first sale Mar 2018

  3. Oct 2017
    Round$25M1 new

    Reported by FinSMEsSEC filing: $15M sold, first sale Oct 2017

  4. Nov 2014
    Venture$500K

    No investor was named in the report.

    From a historical funding recordSEC filing: $500K sold, first sale Nov 2014

  5. Oct 2014
    Venture$45M

    No investor was named in the report.

    From a historical funding recordSEC filing: $45M sold, first sale Oct 2014

  6. Aug 2013
    Growth$6.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $6.0M sold, first sale Aug 2013

Founders and team

From TELA Bio's own website and the SEC filings it signed: 11 on the team.

  • Heather C. GetzChief Executive Officer
  • Jason GugliuzzaSenior Vice President - TELA Bio Europe
  • Jennifer ArmstrongSenior Vice President – Human Resources
  • Jeffrey BlizardPresident
  • Megan SmeykalChief Accounting Officer & Controller
  • Paul TalmoChief Science and Innovation Officer
  • Joseph CapperChairman
  • Antony KoblishExecutive Officer, Directori
  • Francis ConwayExecutive Officeri
  • Maarten PersenaireExecutive Officeri
  • Nora J. BrennanExecutive Officeri

On the board, as filediAdele OlivaAshley FriedmanKurt AzarbarzinMatt ZugaRonald J. EllisVince Burgess

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Growth2013Venture2014Venture2014Round2017Round2018Debt2025OrbiMedPerceptive AdvisorsProMedicaPacira Pharmaceuticals

Everyone who backed them

OrbiMedPrivate equity1round
Perceptive AdvisorsAsset manager1round
ProMedicaVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list TELA Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Signet Healthcare PartnersVC firmPer its own site
HighCape PartnersVC firmPer its own site
Checkmate CapitalPrivate equityPer its own site

Quick answers about TELA Bio

Who invested in TELA Bio?

TELA Bio's investors include OrbiMed, Perceptive Advisors, ProMedica and Pacira Pharmaceuticals.

How much has TELA Bio raised?

TELA Bio has raised $138M across 6 rounds since 2013.

When did TELA Bio last raise?

TELA Bio's most recent round was a Debt of $60M in Nov 2025.

What was TELA Bio's biggest round?

Its most recent round, $60M in Nov 2025, is also its largest on record.

Who backed TELA Bio first?

TELA Bio's first round on record, in Oct 2017, was backed by Pacira Pharmaceuticals.

What stage is TELA Bio at?

TELA Bio's latest named round is a Debt, in Nov 2025.

Where is TELA Bio based?

TELA Bio is based in the United States.

Companies like TELA Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.